Data de publicação: 13/10/2021 - 15:53
Fiocruz will be part, starting next week, of a Phase 3 international multicenter study with the drug Molnupiravir, manufactured by the pharmaceutical company MSD. The goal is to verify its efficiency to prevent the COVID-19 spread and transmission among people exposed to the Sars-CoV-2 virus. The study will occur simultaneously in seven centers in Brazil, two of which are under the Fiocruz responsibility: Mato Grosso do Sul and Rio de Janeiro....
Notícias
Data de publicação: 13/10/2021 - 11:13
The ambassador of Botswana to Brazil, Tebogo Montshome, visited Fiocruz last Thursday (October 7th). She decided to get to know the Foundation while visiting Rio de Janeiro to identify areas of possible cooperation between her country and the institution. Greeted by the Vice-President of Production and Innovation in Health, Marco Krieger, Montshome was particularly interested in staff training, research and production of drugs and vaccines....
Notícias
Data de publicação: 07/10/2021 - 17:11
A new study by Fiocruz on the effectiveness of vaccination in Brazil shows that the population has benefitted from the vaccination plan against the Sars-CoV-2 in the prevention of severe cases and deaths by Covid-19, although effectiveness varies between age groups. The analysis, which also included subjects vaccinated with the first dose of the Pfizer shot, was carried out between January 17 and July 19 this year, a total of six months, in...
Notícias
Data de publicação: 07/10/2021 - 14:50
In the first decades of the twentieth century, the American multinational United Fruit Company, prominent in the production and sale of tropical fruits, found a way to deal with malnutrition among its workers in Costa Rica: it imported canned and processed foods from the United States. At the same time, the solution to high infant mortality in the banana plantation zone was the introduction of an artificial food developed by Nestlé. Years...
Notícias
Data de publicação: 05/10/2021 - 17:22
Large-scale deforestation of the Amazon forest associated with climate change will increase the risk of exposure to extreme heat. Such levels of heat, which will be physiologically intolerable for the human body, will profoundly affect regions inhabited by highly vulnerable populations, according to a study published by researchers Beatriz Alves de Oliveira, of Fiocruz; Marcus Bottino and Paulo Nobre, both of the National Institute of Space...
Notícias
Data de publicação: 05/10/2021 - 16:32
The Evandro Chagas National Institute of Infectious Diseases (INI/Fiocruz) is now open for enrollment, up to November 1, into the Fourth International Course on Immunohistochemistry, Molecular Pathology and Histopathology for the Diagnosis of Infectious Diseases. Coordinated by Rodrigo Caldas Menezes, Luiz Cláudio Ferreira and Leonardo Pereira Quintella, the training is aimed at healthcare professionals, especially those that work or...
Notícias
Data de publicação: 04/10/2021 - 10:54
The COVID-19 pandemic was one of the main subjects discussed at two meetings that drew the attention of the entire world and of the region last week. While chiefs of state and of government debated the effects of the disease at the 76th General Assembly of the United Nations, at the 59th Board of Directors and 73rd Session of the Regional Committee of the World Health Organization (WHO) for the Americas, organized by the Pan-American Health...
Notícias
Data de publicação: 30/09/2021 - 14:08
By means of its Immunobiological Technology Institute (Bio-Manguinhos), last Monday (September 27th) Fiocruz ended the production of the first batches called pre-validation batches of the national Active Pharmaceutical Ingredient (API) for the COVID-19 vaccine. The ingredient will now be submitted to quality control tests at the institution to then be sent to the final processing phase of the vaccine. The first pre-validation batch, which was...
Notícias
Data de publicação: 24/09/2021 - 10:24
As part of the preparations for the new Brazilian expedition to Antarctica, Fiocruz donated 3,000 rapid tests to detect Sars-Cov-2 antigens to the Navy. The kits, produced by the Institute of Technology in Immunobiologicals (Bio-Manguinhos/Fiocruz), will be used to test the entire crew on board, on the support flights, the team at the Comandante Ferraz Antarctic Station and the researchers who will be part of the new trip - including the...
Notícias
Data de publicação: 21/09/2021 - 15:20
Researcher Jorge Bermudez, chief of the Department of Medicines Policy and Pharmaceutical Services at the Sergio Arouca National School of Public Health (ENSP/Fiocruz, in the Portuguese acronym), is now a member of the Technical Advisory Group (TAG) created to advise the World Health Organization (WHO) in scientific, technical and strategic issues related to COVID-19 Technology Access Pool (C-TAP). C-TAP is a solidarity mechanism launched...
Notícias
Data de publicação: 04/09/2021 - 12:50
The world is ageing, and it is not only in the wealthiest countries. In Brazil, this matter has an aggravating factor: while more developed nations become rich first and then age, Brazil is ageing in poverty, warns Alexandre Kalache. The president of the International Longevity Centre in Brazil, who is a doctor, was the mediator in the webinar Ageing, demographic changes and the pandemic, of the Fiocruz Global Health Center (CRIS/Fiocruz),...
Notícias
Data de publicação: 03/09/2021 - 13:06
Despite the restrictions imposed due to the pandemic, the team at the Laboratory for Clinical Research on Mycobacterioses of the Evandro Chagas National Institute of Infectology (INI/Fiocruz) considers 2021 a year of great advances. "Besides the adaptation to work in home office and the remote service implementation for patients, we have been contemplated in different national and international initiatives. This allows us to carry out new...
Notícias
Data de publicação: 02/09/2021 - 17:05
A study conducted by Brazilian researchers shows how age influences the effectiveness of the two main immunizers used in the country against COVID-19. Submitted as a preprint in MedRxiv, the study Influence of age on effectiveness and duration of protection in the Oxford/AstraZeneca and CoronaVac vaccines involved more than 75 million immunized people, becoming the largest study conducted with the two immunizers and may serve as a basis for...
Notícias
Data de publicação: 31/08/2021 - 13:20
An unprecedented survey by the Oswaldo Cruz Foundation (Fiocruz) shows that the number of COVID-19 deaths in Brazil in 2020 was 18.2% higher than recorded. The analysis indicated that there were 230,452 deaths from the disease last year, not 194,949. The results of the study, funded by the Fiocruz Program to Foster Innovation (Inova Fiocruz), will be published in the Fiocruz COVID-19 Monitoring panel.
Coordinator of the study, Cristiano...
Notícias
Data de publicação: 31/08/2021 - 10:26
The release of Aedes aegypti mosquitoes carrying Wolbachia in Niterói, in the state of Rio de Janeiro, which began as a pilot action in Jururuba, in 2015, and covered 75% of the city’s territory, has already yielded positive effects. Data released this Thursday (August 26th) by the Wolbachia Method, an initiative of the World Mosquito Program (WMP) led by Fiocruz in Brazil, indicate a reduction of about 70% of cases of dengue fever...
Notícias
Data de publicação: 25/08/2021 - 12:33
Effectiveness studies of COVID-19 vaccines have demonstrated the immunization importance for protection against severe cases and hospitalization against the new variants. In June, data showed a 92% effectiveness of the AstraZeneca vaccine for hospitalizations against the Delta variant. Now, a new study coordinated by Oxford University in the United Kingdom points out that the Pfizer and AstraZeneca vaccines, this one produced in Brazil by...
Notícias
Data de publicação: 23/08/2021 - 10:04
The post-pandemic perspectives on Agenda 2030 in relation to issues such as health, human rights, and climate were addressed by the Advanced Seminars of the Fiocruz Global Health Center (CRIS/Fiocruz) this Wednesday (August, 18th). The event Agenda 2030: global stocktake and post-pandemic perspectives presented an updated assessment of the Sustainable Development Goals (SDGs) at global, regional and national levels, pointing out criticisms and...
Notícias
Data de publicação: 19/08/2021 - 10:10
In Manaus, the estimated population of pregnant women is 28.4 thousand, and of postpartum women, 4.7 thousand. According to data from the COVID-19 Manaus Vaccinometer, so far, only 6,606 pregnant women and 1,680 mothers have received the first dose of the vaccine. Coordinated by researchers from the Leônidas & Maria Deane Institute (Fiocruz Amazônia) and the Universidade Federal do Amazonas (UFAM), a study is investigating the...
Notícias
Data de publicação: 12/08/2021 - 11:20
Fiocruz, the State Government of Ceará and the State University of Ceará (UECE, acronym in Portuguese) sealed, this Thursday (8/5), a cooperation agreement for the development and production of the HH-120-Defenser vaccine against COVID-19, the elaboration of research projects and technological development. The agreement, signed by the Fiocruz president, Nísia Trindade Lima, and the Ceará governor, Camilo Santana...
Notícias
Data de publicação: 04/08/2021 - 17:11
An African word, Ubuntu, should guide the world leaders as a principle to tackle the COVID-19 pandemic. The statement is part of the commentary “COVID-19 pandemic, R&D, vaccines, and the urgent need of UBUNTU practice”, published by The Lancet Regional Health – Americas in its first edition.
This Bantu language-derived African word reflects humanity and the interconnection amongst humans. As an example, the text...
Notícias
Data de publicação: 03/08/2021 - 14:40
By means of the Immunobiological Technology Institute (Bio-Manguinhos/Fiocruz), Fiocruz has reached 80.4 million doses of the COVID-19 vaccine made available to the National Immunization Program (PNI, in the Portuguese acronym), delivering approximately 2.2 million doses this Friday (July 30th). Of these, 76.4 million were processed at Fiocruz and 4 million were imported ready to use from the Serum Institute, in India. Another milestone of the...
Notícias
Data de publicação: 29/07/2021 - 11:19
Three projects led by Fiocruz researchers are among the ten selected worldwide by the Grand Challenges ICODA COVID-19 Data Science, an initiative that supports health data projects to respond more accurately to the pandemic and possible challenges in the future. With support from the Bill & Melinda Gates Foundation, the Minderoo Foundation, and Microsoft's AI for Health program, they will receive a fund of US$100,000 for their...
Notícias
Data de publicação: 26/07/2021 - 19:07
The largest set of favelas in Rio de Janeiro, with about 140,000 inhabitants, Maré will be the home of a study led by Fiocruz on the impact of COVID-19 vaccination on its population. The initiative is a collaboration between the Networks of Maré, Rio de Janeiro’s City Hall by means of the Municipal Secretariat of Health, and Fiocruz. Taking into account the peculiarities in territories that include favelas and peripheral...
Notícias
Data de publicação: 21/07/2021 - 12:53
The implications of the fact that the pandemic is hitting younger people in Brazil are the subject of the paper Younger Brazilians hit by COVID-19 – What are the implications?, by researchers of the Fiocruz COVID-19 Observatory, published in a magazine of The Lancet group on July 14th. Following the observation that COVID-19 cases in younger age groups (adults between 20 and 59 years of age) that evolved into severe conditions and...
Notícias
Data de publicação: 16/07/2021 - 13:42
The dispersion of diseases in the Amazon is directly related to the agricultural development trajectory of municipalities and the loss of biodiversity. Malaria is prevalent in municipalities with an agro-extractivist profile and with forest cover, that is, half of the Amazon territory. Dengue and chikungunya occur more frequently in municipalities of recent urban expansion, such as on the southern edge of the Amazon in transition to the Cerrado...
Notícias
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
